Affiliation:
1. Department of Microbiology and Immunology, Emory University School of Medicine, Emory Antibiotic Resistance Center, Atlanta, Georgia, USA
Abstract
ABSTRACT
Clostridioides difficile
is an anaerobic gastrointestinal pathogen that spreads through the environment as dormant spores. To survive, replicate, and sporulate in the host intestine,
C. difficile
must adapt to a variety of conditions in its environment, including changes in pH, the availability of metabolites, host immune factors, and a diverse array of other species. Prior studies showed that changes in intestinal conditions, such as pH, can affect
C. difficile
toxin production, spore formation, and cell survival. However, little is understood about the specific genes and pathways that facilitate environmental adaptation and lead to changes in
C. difficile
cell outcomes. In this study, we investigated two genes,
CD2505
and
CD2506,
that are differentially regulated by pH to determine if they impact
C. difficile
growth and sporulation. Using deletion mutants, we examined the effects of both genes (herein
smrR
and
smrT
) on sporulation frequency, toxin production, and antimicrobial resistance. We determined that SmrR is a repressor of
smrRT
that responds to pH and suppresses sporulation and toxin production through regulation of the SmrT transporter. Further, we showed that SmrT confers resistance to erythromycin and lincomycin, establishing a connection between the regulation of sporulation and antimicrobial resistance.
IMPORTANCE
Clostridioides difficile
is a mammalian pathogen that colonizes the large intestine and produces toxins that lead to severe diarrheal disease.
C. difficile
is a major threat to public health due to its intrinsic resistance to antimicrobials and its ability to form dormant spores that are easily spread from host to host. In this study, we examined the contribution of two genes,
smrR
and
smrT
, on sporulation, toxin production, and antimicrobial resistance. Our results indicate that SmrR represses
smrT
expression, while production of SmrT increases spore and toxin production, as well as resistance to antibiotics.
Funder
HHS | NIH | National Institute of Allergy and Infectious Diseases
Publisher
American Society for Microbiology